GlaxoSmithKline's Experiences with Life Cycle Assessment

GlaxoSmithKline has investigated life cycle impacts in the pharmaceutical supply chain for more thana decade, incorporating life cycle inventory and assessment (LCI/A) tools within metrics, tools and decision systems within the organization to drive towards more sustainable business pactices. This presentation intends to briefly cover GSK's experiencies in developing, applying and embedding LCI/A concepts, metrics and tools into business process.